PQLI Application of Science- and Risk-based Approaches (ICH Q8, Q9, and Q10) to Existing Products
暂无分享,去创建一个
This paper describes progress made by the Legacy Products Task Team within the ISPE Product Quality Lifecycle Implementation (PQLI) initiative. It discusses the opportunities and the required business and technical processes to justify and deliver a quality by design (QbD) project for an existing product. A process flow is included that summarizes business, technical, and regulatory considerations. A quality risk management-based approach is suggested. Relevant case studies also are presented. Comments are welcome.
[1] John Lepore,et al. PQLI Design Space , 2008, Journal of Pharmaceutical Innovation.
[2] Roger Nosal,et al. PQLI Definition of Criticality , 2008, Journal of Pharmaceutical Innovation.
[3] J. Abraham. The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use , 2009 .
[4] Bruce Davis,et al. PQLI Control Strategy Model and Concepts , 2008, Journal of Pharmaceutical Innovation.